SPTLC1 variants associated with childhood onset amyotrophic lateral sclerosis produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins
Museer A. Lone(University of Zurich), Thorsten Hornemann(University Hospital of Zurich)
Cited by 1
Related Papers
DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans
|Journal of Clinical Investigation|2019|129
SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins
|Journal of Clinical Investigation|2022|59